THE SMART SOLUTION FOR
CLINICAL BIOMARKER DEVELOPMENT & IMPLEMENTATION
Noble can develop strategies for the management of therapeutic, clinical and business aspects of your R&D program including:
Inclusive project and technology management for transitioning your candidate biomarker to a robust clinically viable test
Preclinical analysis of targets and biomarkers for identification of patient subpopulations that have enhanced potential for clinical activity
Identification and validation of patient stratification biomarkers in clinical samples
Evaluation of potential rationale combination therapies using cellular, animal, and clinical data analysis
Clinical study design and implementation of biomarker strategies
Evaluation and diligence for licensing and acquisition of technologies and business
We have experience with a variety of mammalian species used for vaccine and drug development. Our studies range from single digit to hundreds of animals.
Our scientists, with over 15 years of GLP experience, provide all aspects of the GLP process from design to regulatory support of your IND, IDE or PMA FDA submission.